Цена на акция и новини за Arbutus Biopharma Corp (ABUS)

Начална страницаABUS • NASDAQ

Arbutus Biopharma Corp

4,26 $

16.03, 8:20:34 ч. Гринуич-4 · USD · NASDAQ · Отказ от отговорност

Борсови котировкиЦенна книга, търгувана в(ъв) САЩЦентрален офис в(ъв) САЩ

Цена при затв. на предх. ден

4,26 $

Диапазон за годината

2,71 $ - 5,10 $

Пазарна капитализация

819,30 млн. USD

Среден обем

2,67 млн.

Съотношение цена/печалба

Постъпления от дивиденти

Основна борса

NASDAQ

Пазарни новини

GlobeNewswire

преди 16 минути

JFB (NASDAQ: JFB) Announces XTEND and Rayonix Execute

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

Cycurion (Nasdaq: CYCU) Announces Definitive Agreement to Acquire Federal Cybersecurity Firm and Reports Record Contracted Backlog Exceeding $150 Million

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

CareCloud to Ring Nasdaq Closing Bell on May 19, 2026 and Host Analyst Day at Nasdaq MarketSite in New York City

CCLD

7,90%

Информация

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Главен изпълнителен директор

Уилям Х. Колиър

Основаване

2007

Централен офис

Warminster Township, Пенсилвания
Съединени щати

Уебсайт

arbutusbio.com

Служители